Delivery Order SPE2DB24D2213-SPE2DB25FGVEN
Award Date
10/31/24
Potential Completion Date
11/1/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,252.29 firm fixed-price delivery order is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has an ultimate completion date of June 25, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,632.54 firm fixed-price delivery order is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of November 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,878.34, is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The award has an ultimate completion date of May 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to the pharmaceutical distributor Amerisourcebergen Drug Corp. The contract, valued at $22,754.00, is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The contract has an ultimate completion date of December 4, 2024 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and the contract is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,310.69 firm fixed-price delivery order is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has an ultimate completion date of May 19, 2025 and was awarded on May 16, 2025. Amerisourcebergen Drug Corp is a for-profit organization based in Conshohocken,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,885.50, is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract is a firm-fixed-price delivery order with a period of performance through March 31, 2025. AmerisourceBergen is a for-profit organization that has a significant...
This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,480.30 firm fixed-price contract is for the supply of Mounjaro 7.5 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of diabetes. The contract has a period of performance through December 18, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the Defense Logistics...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,135.82, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. This contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization that specializes in distributing a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,265.08 contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a diabetes medication. The order has a completion date of May 8, 2025 and is not set aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,038.17 firm fixed-price contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...